Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy
NCT ID: NCT05246631
Last Updated: 2022-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
80 participants
INTERVENTIONAL
2020-01-01
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine on Postoperative Delirium and Quality of Recovery in Geriatric Patients
NCT01283412
Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery
NCT01149616
Dexmedetomidine Adjuvant to General Anesthesia of Abdominal Hysterectomy
NCT03600506
Dexmedetomidine vs Propofol Sedation Reduces Postoperative Delirium in Patients Receiving Hip Arthroplasty.
NCT02793986
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
NCT00318955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone
5 mg intravenous dexamethasone
Dexamethasone injection
Group A consisted of patients given 5 mg intravenous dexamethasone after induction.
Haloperidol
1 mg intravenous haloperidol
Haloperidol Injection
Group B consisted of patients given 1 mg intravenous haloperidol one hour before the surgery ended
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone injection
Group A consisted of patients given 5 mg intravenous dexamethasone after induction.
Haloperidol Injection
Group B consisted of patients given 1 mg intravenous haloperidol one hour before the surgery ended
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologist (ASA) physical status 1-3
Exclusion Criteria
* history of allergic reaction to dexamethasone or haloperidol
* diabetes mellitus
* did not give the consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aldy Heriwardito
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aldy Heriwardito, Doctor
Role: PRINCIPAL_INVESTIGATOR
Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo Central National Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IndonesiaUAnes393
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.